Reported covered position: Health Policy Intern, Senate HELP Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Great Ape Protection and Cost Savings Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Great Ape Protection and Cost Savings Act of 2011
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Source: Senate LDA
| RELX INC. |
| 16 |
| 2008–2012 |
| NOVARTIS SERVICES, INC. | 13 | 2008–2011 |
| GENZYME | 12 | 2008–2011 |
| EMD SERONO, INC. | 11 | 2009–2012 |
| WINNING STRATEGIES WASHINGTON LLC | 11 | 2009–2010 |
| KINDRED HEALTHCARE INC | 10 | 2009–2011 |
| SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT INC | 10 | 2009–2011 |
| THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER | 7 | 2008–2009 |
| HENRY SCHEIN INC | 6 | 2011 |
| INTERNET2 | 6 | 2008–2009 |
| VIROPHARMA INCORPORATED | 6 | 2011–2012 |
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE | 5 | 2011–2012 |
| ASS'N OF PRIVATE SECTOR COLLEGES AND UNIVERSITIES (FKA CAREER COLLEGE ASS'N) | 4 | 2010–2011 |
| POLICY STUDIES, INC | 4 | 2009 |
| SOMNOMED, INC. | 3 | 2011 |
| VITAL CARE, INC. | 3 | 2011 |
| AMPHASTAR PHARMACEUTICALS INC | 2 | 2009 |
| CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION | 2 | 2010 |
| GENENTECH | 2 | 2009 |
| GOOGLE INC. | 2 | 2009 |
| LPC PROPERTY MANAGEMENT, INC | 2 | 2011 |
| QUEST DIAGNOSTICS INCORPORATED | 2 | 2011 |
| ALLIANCE FOR QUALITY NURSING HOME CARE | 1 | 2010 |
| AMGEN | 1 | 2011 |
| NATIONAL HISPANIC COUNCIL ON AGING | 1 | 2011 |
| UNIVERSAL AMERICAN CORPORATION | 1 | 2011 |
Great Ape Protection and Cost Savings Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill).
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act "Track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Food and Drug Administration Reform Act of 2012
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation.
Food and Drug Administration Reform Act of 2012
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: VIROPHARMA INCORPORATED · Firm: PODESTA GROUP, INC.
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases. Coverage of rare disease therapies.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Food and Drug Administration Reform Act of 2012
Client: VIROPHARMA INCORPORATED · Firm: PODESTA GROUP, INC.
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases.
Food and Drug Administration Reform Act of 2012
Client: VIROPHARMA INCORPORATED · Firm: PODESTA GROUP, INC.
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases. Coverage of rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · third_quarter · 3A
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes. S. 3463, Medicare Diabetes Prevention Act of 2012.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
RELX INC via PODESTA GROUP, INC.
2012 · third_quarter · 3A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2012 · third_quarter · Q3
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
EISAI INC. via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
COVIDIEN via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes research issues.
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2012 · second_quarter · Q2
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill).
COVIDIEN via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
EISAI INC. via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation.
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act "Track and trace" issues.
EMD SERONO INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation. S. 425, National Neurological Diseases Surveillance System Act of 2011
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions).
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2012 · first_quarter · Q1
FDA issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes research issues.
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
EISAI INC. via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
VITAL CARE, INC. via PODESTA GROUP, INC.
2011 · third_quarter · 3A
CMS payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · 4@
Advocacy related to distribution contracts for federal vaccine programs. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012 S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012.
Advocacy related to distribution contracts for federal vaccine programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LPC PROPERTY MANAGEMENT, INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Military housing policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LPC PROPERTY MANAGEMENT, INC via PODESTA GROUP, INC.
2011 · fourth_quarter · RR
Military housing policy.
SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · 4T
Patient Protection and Affordable Care Act implementation. Medicare and Medicaid funding. S. 1486, Long-Term Care Hospital Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Advocacy related to distribution contracts for federal vaccine programs.
Advocacy related to distribution contracts for federal vaccine programs. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012 S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011.
EMD SERONO INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation. S. 425, National Neurological Diseases Surveillance System Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
FDA issues. Medicare and Medicaid reimbursement.
FDA issues. Medicare and Medicaid reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1486 Long-Term Care Hospital Improvement Act of 2011.
Medicare Part B therapy services. Regulation of long term acute care hospitals; education and development of new legislation for LTAC patient & facility criteria. Independent rehabilitiation facilities. CMS proposed rule changes. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1486 Long-Term Care Hospital Improvement Act of 2011.
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Diabetes issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
EISAI INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Student Loan Auction Rate Securities (SLARS). H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Medicare coverage and reimbursement issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
2011 · fourth_quarter · Q4
Medicare Part B reimbursement and coverage of dialysis products. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Filing targets: Council of Economic Advisers (CEA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2011 · fourth_quarter · RR
FDA issues. Medicare and Medicaid reimbursement.
FDA issues. Medicare and Medicaid reimbursement.
VITAL CARE, INC. via PODESTA GROUP, INC.
2011 · third_quarter · 3A
CMS payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC. via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Patient Protection and Affordable Care Act implementation. Medicare and Medicaid reform, generally. S. 1486, Long-Term Care Hospital Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2011 · third_quarter · Q3
FY 2012 Budget Resolutions (diabetes-related issues). S. 1599, FY 2012 Labor-HHS Appropriations. H.R. 2112, FY 2012 Agriculture Appropriations. National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation.
Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding minority health, diabetes screening, National Diabetes Prevention Program. H.R. 2954, The Health Equity and Accountability Act of 2011. H.R. 2960, National Diabetes Clinical Care Commission Act. S. 1599, FY 2012 Labor-HHS Appropriations.
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Advocacy related to distribution contracts for federal vaccine programs.
Advocacy related to distribution contracts for federal vaccine programs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI INC. via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Alzheimer's issues. Patient Protection and Affordable Care Act implementation. Monitor debt ceiling negotiations. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Student Loan Auction Rate Securities (SLARS). H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Drug issues. Prescription Drug User Fee Act reauthorization. FDA-DEA issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
COVIDIEN via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
H.R. 1249 / S. 23, America Invents Act.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAL CARE, INC. via PODESTA GROUP, INC.
2011 · third_quarter · Q3
CMS payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SOMNOMED, INC. via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Veterans health care policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · third_quarter · Q3
H.R. 1249/S. 23, America Invents Act.
FY 2012 budget resolutions. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Medicare coverage and reimbursement. Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Medicare Part B therapy services. Regulation of long term acute care hospitals; education and development of new legislation for LTAC patient & facility criteria. Independent rehabilitiation facilities. CMS proposed rule changes. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1486 Long-Term Care Hospital Improvement Act of 2011.
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1486 Long-Term Care Hospital Improvement Act of 2011.
EMD SERONO INC via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation. S. 425, National Neurological Diseases Surveillance System Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. Medicare reimbursement issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Antibiotic resistance issues. H.R. 2182, Generating Antibiotic Incentives Now Act of 2011. Pay-for-delay proposals and generic issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues.
Medicare coverage and reimbursement issues. Monitor debt ceiling negotiations. Diabetes issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes issues. Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
SOMNOMED, INC. via PODESTA GROUP, INC.
2011 · third_quarter · RA
Veterans health care policy.
NATIONAL HISPANIC COUNCIL ON AGING via PODESTA GROUP, INC.
2011 · third_quarter · RR
Medicare, Medicaid, Older Americans Act.
Medicare, Medicaid, Older Americans Act.
SOMNOMED, INC. via PODESTA GROUP, INC.
2011 · second_quarter · RR
Veterans health care policy.
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Medicare reimbursement related to the 2011 Physician Fee Schedule, provisions in the Affordable Care Act and federal budget negotiations (no specific bills). Self-referral abuses relating to anatomic pathology (no specific bills). Physicians' signature requirement on laboratory requisitions.
Oversight of laboratory services and genetic information and testing (no specific bills). H.R. 2194 / S. 1221, Gestational Diabetes Act.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC. via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Patient Protection and Affordable Care Act implementation. Monitor Medicare reform. HIPAA compliance issues.
Filing targets: HOUSE OF REPRESENTATIVES
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Advocacy related to distribution contracts for federal vaccine programs.
Advocacy related to distribution contracts for federal vaccine programs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN via PODESTA GROUP, INC.
2011 · second_quarter · Q2
H.R. 1249 / S. 23, America Invents Act.
Issues involving controlled substances and pain and addiction drugs generally. Issues related to acetaminophen.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization.
Diabetes-related issues, generally. H.R. 1473, Department of Defense and Full-year Continuing Appropriations Act of 2011
Diabetes screening. Diabetes-related issues, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011.
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Medicare Part B therapy services. Regulation of long term acute care hospitals; education and development of new legislation for LTAC patient & facility criteria. Independent rehabilitiation facilities. CMS proposed rule changes.
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Health IT issues; waste, fraud, and abuse issues. H.R. 173, Medicare Fraud Prevention Act of 2011 H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 S. 1251, Medicare and Medicaid FAST Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Patient Protection and Affordable Care Act implementation. 340B-related issues.
Medicare coverage and reimbursement. Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Alzheimer's issues. Patient Protection and Affordable Care Act implementation. Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Drug issues, generally. Prescription Drug User Fee Act reauthorization. FDA-DEA issues, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · second_quarter · Q2
H.R. 1249/S. 23, America Invents Act.
Medicare home infusion and reimbursement issues. 340B issues H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011
Medical research. Antibiotic resistance issues.
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2011 · second_quarter · Q2
Diabetes research issues. Debt Ceiling (not bill yet, just the topic) HR 1473 Department of Defense and Full-year Continuing Appropriation Act of 2011
Prescription Drug User Fee Act reauthorization. FDA issues, generally.
Diabetes issues, generally. Patient Protection and Affordable Care Act implementation. Monitor debt ceiling negotiations. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2011 · first_quarter · 1A
Diabetes research issues.
Prescription Drug User Fee Act reauthorization. FDA issues, generally.
Diabetes issues, generally. Patient Protection and Affordable Care Act implementation.
UNIVERSAL AMERICAN CORPORATION via PODESTA GROUP, INC.
2011 · first_quarter · 1T
Medicare Advantage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC. via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Patient Protection and Affordable Care Act impliementation.
Medical malpractice reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Medicare Part B therapy services. Regulation of long term acute care hospitals. Independent rehabilitiation facilities. CMS proposed rule changes.
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · first_quarter · Q1
H.R. 1249/S. 23, America Invents Act.
Prescription Drug User Fee Act reauthorization.
Patient Protection and Affordable Care Act implementation.
GENZYME via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Patient Protection and Affordable Care Act implementation.
Prescription Drug User Fee Act reauthorization.
FY 2011 and 2012 budget appropriations.
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Medical research. Antibiotic resistance issues.
H.R. 1249/S. 23, America Invents Act.
Antibiotic resistance issues. GAIN: Generating Antibiotic Incentives Now Act of 2011
ASS'N OF PRIVATE SECTOR COLLEGES AND UNIVERSITIES (FKA CAREER COLLEGE ASS'N) via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Higher education legislation and rulemaking.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2011 · first_quarter · Q1
H.R. 1249/S. 23, America Invents Act.
Medicare coverage and reimbursement issues.
Diabetes issues, generally. Patient Protection and Affordable Care Act implementation.
RELX INC via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Health IT issues; waste, fraud, and abuse issues. H.R. 173, Medicare Fraud Prevention Act of 2011 H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Reimbursement and oversight of clinical laboratory services; regulation of clinical laboratory testing, Oversight of laboratory diagnostic products. Oversight of health information and health information systems and incentives for use of such systems. Health care reform including wellness issues and entities created by the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2011 · first_quarter · Q1
H.R. 1, Full Year Continuing Appropriations Act, 2011. H.J. Res. 44, Further Continuing Appropriations Amendments, 2011. H.J. Res. 48, Further Continuing Appropriations Amendments, 2011. FY 2012 Budget Resolutions (diabetes-related issues)
Diabetes-related issues, generally.
Prescription Drug User Fee Act reauthorization.
NOVARTIS SERVICES, INC. via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Transformational Medical Technologies Initiative.
Vaccine issues. Pandemic influenza issues. Patient Protection and Affordable Care Act implementation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Center for Medicare and Medicaid Services proposed rules. Payment for home health services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Advocacy related to distribution contracts for federal vaccine programs.
Advocacy related to distribution contracts for federal vaccine programs.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI INC. via PODESTA GROUP, INC.
2011 · first_quarter · Q1
Medicare coverage and reimbursement issues.
Drug issues, generally. Prescription Drug User Fee Act reauthorization.
Alzheimer's issues. Patient Protection and Affordable Care Act implementation.
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes. S. 3463, Medicare Diabetes Prevention Act of 2012.
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes-related issues.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Diabetes research issues.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Pub. L. 112-29, Leahy-Smith America Invents Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare coverage and reimbursement issues. Diabetes issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes research issues. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Alzheimer's issues. Breast cancer efforts. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Student Loan Auction Rate Securities (SLARS) H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Drug issues. Prescription Drug User Fee Act reauthorization. FDA-DEA issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes screening. Diabetes-related issues. H.R. 2741, Preventing Diabetes in Medicare Act of 2011. Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 implementation. Medicaid rebates. ASP changes. 340B changes.
Diabetes-related issues.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Student Loan Auction Rate Securities (SLARS) H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Medicare coverage and reimbursement issues. Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. H.R. 2112, Agriculture Appropriations. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
340B-related issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Monitor debt ceiling negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2012 budget resolutions. FY 2011/2012 appropriations for antibiotic resistance research. Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1599, Labor-HHS Appropriations.
Medical research. Antibiotic resistance issues. H.R. 2182, Generating Antibiotic Incentives Now Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes research issues. Monitor debt ceiling negotiations. H.R. 1599, Labor-HHS Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patient Protection and Affordable Care Act implementation.
FY 2012 Budget Resolutions (diabetes-related issues) H.R. 1473, Department of Defense and Full-year Continuing Appropriation Act of 2011 FY 2012 Labor-HHS Appropriations National Diabetes Prevention Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2012 budget resolutions. FY 2011/2012 appropriations for antibiotic resistance research. Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1249/S. 23, America Invents Act.
Medicare coverage and reimbursement issues. Debt Ceiling (not bill yet, just the topic) H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1249/S. 23, America Invents Act.
Medicare coverage and reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare coverage and reimbursement.
FY 2012 Budget resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare issues related to end stage renal disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1, Full Year Continuing Appropriations Act, 2011 H.J. Res. 44 and 48, Further Continuing Appropriations Amendments, 2011 FY 2012 Budget resolutions. FY 2011/2012 appropriations for antibiotic resistance research.
Medicare home infusion and reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes research issues.
Prescription Drug User Fee Act reauthorization. FDA issues, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patient Protection and Affordable Care Act implementation.
H.R. 1249/S. 23, America Invents Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1249/S. 23, America Invents Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE